The 90 mil missing shares in the registry you repeatedly mentioned are one of the keys to understand what is happening here, in my opinion.
It is not straight accumulation as such but rather facilitating and accommodating services for at least 2 entities working together, one selling, the other profiting from the low share price in order to convert notes to favourable prices, then switching roles and allowing the first one to re-purshase his/ her outlet.
All IMO.
But I would go further than this, as above mentioned is becoming an old hat and rather describes the past than the events unfolding.
I personally see instos to move into this stock, regulating the price so that it suits all involved.
Companies on the verge of transitioning towards a strong revenue generating entity are usually targets for larger players to position themselves accordingly.
This is excactly what can be observed here for some time now, as I see it.
Bergen might sell its shares at a higher price, but the amount of shares in a possible swap allowing for a 10 percent stake in the company which is a good start in accumulating towards control of the company.
This stock was too tightly held for instos to work along those lines.
Bergen notes/ conversions and possible sophs issuances will alleviate this problem for those who might want to get a foot into the door early to be able to control events in years to come.
Instos which would position themselves in that fashion would massively accumulate further after positive, company making news, which we all expect from the medical, energy and
POC divisions.
- Forums
- ASX - By Stock
- ADO
- An absolute disgrace
ADO
anteotech ltd
Add to My Watchlist
0.00%
!
1.3¢

An absolute disgrace, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.16M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $10.88K | 843.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 246504 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 2711219 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1901789 | 0.012 |
9 | 2353674 | 0.011 |
8 | 3709000 | 0.010 |
10 | 1803777 | 0.009 |
10 | 3571875 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 2711219 | 8 |
0.015 | 4089116 | 12 |
0.016 | 1475197 | 3 |
0.017 | 218695 | 4 |
0.018 | 499000 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online